How effective is ustekinumab in controlling psoriatic arthritis?

Research output: Contribution to journalArticlepeer-review


Recently ustekinumab has been approved for the therapy of psoriatic arthritis (PsA). Some case series have been published reporting new onset of inflammatory arthritis in psoriasis patients treated with ustekinumab. In addition, flare of joint inflammation in PsA patients has also been reported. We describe a case series of seven patients affected by PsA who experienced either a worsening or a flare of inflammatory arthritis during treatment with ustekinumab.

Original languageEnglish
Pages (from-to)155-159
Number of pages5
JournalDermatologic Therapy
Issue number3
Publication statusPublished - May 1 2016


  • psoriasis
  • psoriatic arthritis
  • ustekinumab

ASJC Scopus subject areas

  • Dermatology


Dive into the research topics of 'How effective is ustekinumab in controlling psoriatic arthritis?'. Together they form a unique fingerprint.

Cite this